SCC
BSX icon

Spring Creek Capital’s Boston Scientific BSX Stock Holding History

Spring Creek Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-25,994
Closed -$850K – 125
2018
Q2 		$850K Buy
+25,994
New +$784K 0.1% 187

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Spring Creek Capital's BSX Position: Q3 2018 in Review

Spring Creek Capital sold out of Boston Scientific (BSX) in Q3 2018, closing a stake of 25,994 shares — an estimated $850K sold.

Spring Creek Capital first reported a position in BSX in Q2 2018 and held it in 1 quarter. The position peaked at $850K in Q2 2018. 698 funds tracked by Wall St. Rank hold BSX as of Q3 2018.

  • Spring Creek Capital reported no remaining Boston Scientific position as of Q3 2018 after selling out during the quarter.
  • Spring Creek Capital sold 25,994 Boston Scientific shares in Q3 2018, an estimated $850K.
  • Spring Creek Capital first reported a position in Boston Scientific in Q2 2018 and held it in 1 quarter.
  • Spring Creek Capital's Boston Scientific position peaked at $850K in Q2 2018.
  • 698 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.